{"id":275220,"date":"2026-09-28T14:34:25","date_gmt":"2026-09-28T09:04:25","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=275220"},"modified":"2026-09-28T14:34:25","modified_gmt":"2026-09-28T09:04:25","slug":"why-neuland-laboratories-share-price-price-fall-2026-09-28","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-09-28\/","title":{"rendered":"Neuland Laboratories (NEULANDLAB) Share Price falls 2.04% today"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/neulandlab\/neuland-laboratories-ltd-share-price-today\">Neuland Laboratories (NEULANDLAB)<\/a> share price fell to Rs 21,456.9 today, down 2.04% from the previous close. Market cap was Rs 28,102.52 crore.<\/em><\/div>\n<p class=\"univest-article-timestamp\" style=\"font-size:14px;color:#5F6673;margin:8px 0 18px 0;;margin-top:0!important;margin-bottom:0!important;\"><strong>Published:<\/strong>&nbsp;&nbsp;&nbsp;28 September 2026 at 2:23:10 PM IST<\/p>\n<p style=\"margin-top:0!important;\">Neuland Laboratories Share Price fell to Rs 21,456.90 today, down 2.04% from the previous close, while the company\u2019s market capitalisation stood at Rs 28,102.52 crore. The move places <strong>Neuland Laboratories<\/strong> in focus for <em>Neuland Laboratories Share Price Today<\/em> and <em>Neuland Laboratories Stock News<\/em> searches because the session was clearly weaker than the prior close, even though the supplied data does not establish a company-specific catalyst. On the facts available, today\u2019s decline should be read as a price event first and a story second. Univest is covering the move with a factual lens so readers can track the stock without guessing at reasons that are not verified.<\/p>\n<p>At the same time, the company remains a large-cap name in the Healthcare sector and Pharmaceuticals &amp; Drugs industry. For investors scanning <em>Neuland Laboratories Share Price<\/em> movements, the key question is not only what changed today, but how the current valuation, profitability and peer positioning frame the stock after the fall.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-09-28\/#Neuland_Laboratories_NEULANDLAB_Share_Price_Today_Price_Action_Analysis\" title=\"Neuland Laboratories (NEULANDLAB) Share Price Today: Price Action Analysis\">Neuland Laboratories (NEULANDLAB) Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-09-28\/#Neuland_Laboratories_NEULANDLAB_Fundamental_Analysis\" title=\"Neuland Laboratories (NEULANDLAB) Fundamental Analysis\">Neuland Laboratories (NEULANDLAB) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-09-28\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-09-28\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-09-28\/#Why_Investors_Are_Watching_Neuland_Laboratories\" title=\"Why Investors Are Watching Neuland Laboratories\">Why Investors Are Watching Neuland Laboratories<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-09-28\/#About_Neuland_Laboratories\" title=\"About Neuland Laboratories\">About Neuland Laboratories<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-09-28\/#Track_Neuland_Laboratories_Share_Price_on_Univest\" title=\"Track Neuland Laboratories Share Price on Univest\">Track Neuland Laboratories Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-09-28\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-09-28\/#Why_did_Neuland_Laboratories_Share_Price_fall_today\" title=\"Why did Neuland Laboratories Share Price fall today?\">Why did Neuland Laboratories Share Price fall today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-09-28\/#What_is_Neuland_Laboratories_Share_Price_today\" title=\"What is Neuland Laboratories Share Price today?\">What is Neuland Laboratories Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-09-28\/#What_is_the_market_capitalisation_of_Neuland_Laboratories\" title=\"What is the market capitalisation of Neuland Laboratories?\">What is the market capitalisation of Neuland Laboratories?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-09-28\/#How_does_Neuland_Laboratories_compare_with_its_industry_peers\" title=\"How does Neuland Laboratories compare with its industry peers?\">How does Neuland Laboratories compare with its industry peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-09-28\/#What_do_Neuland_Laboratories_valuation_ratios_show\" title=\"What do Neuland Laboratories\u2019 valuation ratios show?\">What do Neuland Laboratories\u2019 valuation ratios show?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-09-28\/#What_do_EPS_and_book_value_say_about_Neuland_Laboratories\" title=\"What do EPS and book value say about Neuland Laboratories?\">What do EPS and book value say about Neuland Laboratories?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-09-28\/#Is_Neuland_Laboratories_part_of_the_Healthcare_sector\" title=\"Is Neuland Laboratories part of the Healthcare sector?\">Is Neuland Laboratories part of the Healthcare sector?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-09-28\/#What_should_investors_monitor_next_in_Neuland_Laboratories_Share_Price\" title=\"What should investors monitor next in Neuland Laboratories Share Price?\">What should investors monitor next in Neuland Laboratories Share Price?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Neuland_Laboratories_NEULANDLAB_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Neuland Laboratories (NEULANDLAB) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 21,456.9<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 21,903.95<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-Rs 447.05 (-2.04%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 21,763.65<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 21,844.6<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 21,423.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3.09 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 28,102.52 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Large Cap<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Neuland Laboratories Share Price Today shows a decline of Rs 447.05, or 2.04%, with the stock closing at Rs 21,456.90 versus the previous close of Rs 21,903.95. The session opened at Rs 21,763.65, touched a high of Rs 21,844.6 and a low of Rs 21,423.7. That range shows the day stayed within a relatively tight band around the lower end of the opening move, but the visible fact remains simple: the share price fell on the day and finished below the previous close.<\/p>\n<p>The turnover was Rs 3.09 crore. The company\u2019s market-cap category is Large Cap, and its market capitalisation was Rs 28,102.52 crore. Those facts make the move relevant for readers following <em>Neuland Laboratories Share Price News<\/em>,<em>Neuland Laboratories Share Price Update<\/em> and broader <em>Neuland Laboratories Stock Performance<\/em> coverage. Since the workflow confirms a same-day price fall but does not establish a company-specific catalyst, the proper interpretation is to focus on the verified session data and the wider financial context. For investors tracking <em>Neuland Laboratories Share Price Live<\/em>, the next useful step is to compare the fall with the company\u2019s fundamentals and its sector benchmark.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Neuland_Laboratories_NEULANDLAB_Fundamental_Analysis\"><\/span><strong>Neuland Laboratories (NEULANDLAB) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 28,102.52 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">56.46x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.9x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">21.43%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">27.5%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 387.98<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,575.41<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.16%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Neuland Laboratories\u2019 fundamental profile shows a market capitalisation of Rs 28,102.52 crore, which positions it well above the sector median in the supplied peer universe. The stock trades at a P\/E ratio of 56.46 and a P\/B ratio of 13.9, both of which need to be viewed against the Healthcare and Pharmaceuticals &amp; Drugs benchmark rather than in isolation. Its ROE is 21.43% and ROCE is 27.5%, indicating that the business is generating returns above the benchmark medians supplied in the same industry set.<\/p>\n<p>The EPS is Rs 387.98, which shows earnings attributable to each share. Book value is Rs 1,575.41 per share, which gives a simple accounting reference for the equity base behind each share. The dividend yield is 0.16%, a factual payout measure relative to the current share price. For readers searching <em>Neuland Laboratories Fundamental Analysis<\/em> or <em>Neuland Laboratories Financial Results<\/em>, these numbers show a company priced at a premium to the broader industry medians, while still supported by strong returns on equity and capital employed. Univest places these figures in context so that the <em>Neuland Laboratories Share Price<\/em> move is read alongside earnings quality rather than in isolation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">56.46x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">32.87x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">49.63x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.46x to 735.85x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.9x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.85x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.33x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">21.43%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.48%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.04%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">27.5%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.17%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.82%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 28,102.52 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 732.57 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 14,043.26 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The supplied benchmark is the same industry: Pharmaceuticals &amp; Drugs within Healthcare, covering 204 companies. Against that universe, Neuland Laboratories\u2019 P\/E of 56.46 is above the sector median of 32.87 and above the sector average of 49.63. Its P\/B of 13.9 is also well above the sector median of 2.85 and above the sector average of 4.33. On profitability, its ROE of 21.43% sits above the sector median of 11.48% and the sector average of 10.04%, while its ROCE of 27.5% is above the sector median of 13.17% and the sector average of 12.82%.<\/p>\n<p>The market-cap benchmark also matters: the sector median market capitalisation is Rs 732.57 crore, and the sector average is Rs 14,043.26 crore. Neuland Laboratories\u2019 market capitalisation of Rs 28,102.52 crore is above both. This sector context is important for <em>Neuland Laboratories Stock Analysis<\/em> because it shows the company is valued richly relative to the broader industry set, while also producing stronger return ratios than the benchmark norms. Univest uses this comparison to separate price movement from valuation context, which is essential when evaluating <em>Neuland Laboratories Stock News<\/em> and <em>Neuland Laboratories Share News<\/em>.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,44,716.74<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">36.77<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.14<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/divislab\/divi-s-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Divi&#39;s Laboratories<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,55,115.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">87.22<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.44<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,89,613.38<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">86.94<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.13<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,19,899.96<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.57<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.45<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Cipla<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CIPLA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,12,875.68<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.49<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.21<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Within the supplied peer set, Neuland Laboratories sits above several listed pharmaceutical names on returns, but its valuation is also higher than most peers shown. Sun Pharmaceutical Industries has a P\/E of 36.77 and market cap of Rs 4,44,716.74 crore, while Zydus Lifesciences has a P\/E of 26.57 and market cap of Rs 1,19,899.96 crore. Cipla is at a P\/E of 33.49, and Dr. Reddy\u2019s Laboratories is at 31.16.<\/p>\n<p>On profitability, Neuland Laboratories\u2019 ROE of 21.43% is above Sun Pharma, Zydus Lifesciences, Cipla and Dr. Reddy\u2019s in the peer list shown, though it is below Torrent Pharmaceuticals at 26.76% and Lupin at 27.11%. Its ROCE of 27.5% is also stronger than most peers in the sample. For <em>Neuland Laboratories Share Price<\/em> readers, the takeaway is factual: the stock is not the cheapest in the group, but its return ratios stand out versus several comparables.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Neuland_Laboratories\"><\/span><strong>Why Investors Are Watching Neuland Laboratories<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Neuland Laboratories Share Price fell 2.04% today to Rs 21,456.90, below the previous close of Rs 21,903.95.<\/li>\n<li>The day\u2019s open was Rs 21,763.65, the high was Rs 21,844.6 and the low was Rs 21,423.7.<\/li>\n<li>Market capitalisation stood at Rs 28,102.52 crore and the company is classified as Large Cap.<\/li>\n<li>P\/E was 56.46, P\/B was 13.9, ROE was 21.43% and ROCE was 27.5%.<\/li>\n<li>In the industry benchmark, the company\u2019s P\/E, P\/B, ROE and ROCE all sit above the median figures supplied.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Neuland_Laboratories\"><\/span><strong>About Neuland Laboratories<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Neuland Laboratories operates in the Healthcare sector and the Pharmaceuticals &amp; Drugs industry. The supplied data identifies the company through its listed market profile and benchmark universe, which places it among 204 same-industry companies. For readers following <em>Neuland Laboratories Company News<\/em> or <em>Neuland Laboratories Latest News<\/em>, the most useful factual frame is its combination of large-cap size, premium valuation and above-benchmark profitability metrics. Univest presents the stock within this exact sector and industry context so the <em>Neuland Laboratories Share Price<\/em> event can be interpreted against verifiable financial data.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Neuland_Laboratories_Share_Price_on_Univest\"><\/span><strong>Track Neuland Laboratories Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use&nbsp;<a href=\"https:\/\/univest.in\/stocks\/neulandlab\/neuland-laboratories-ltd-share-price-today\">Neuland Laboratories (NEULANDLAB) live share-price page<\/a>,<a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>,<a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top decliners and related market analysis.<\/p>\n<p>Univest helps you track Neuland Laboratories Share Price, current market cap, valuation ratios, return metrics, shareholding pattern and sector comparison in one place. You can also review live stock updates, 52-week levels and market insights for a fuller view of the company\u2019s listed performance.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong>&nbsp;&nbsp;Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_Neuland_Laboratories_Share_Price_fall_today\"><\/span><strong>Why did Neuland Laboratories Share Price fall today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;The supplied data confirms a 2.04% decline in Neuland Laboratories Share Price today, but it does not establish a company-specific catalyst. The stock closed at Rs 21,456.90 versus Rs 21,903.95 previously.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Neuland_Laboratories_Share_Price_today\"><\/span><strong>What is Neuland Laboratories Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Neuland Laboratories Share Price today is Rs 21,456.90. The stock moved down by Rs 447.05, or 2.04%, from the previous close, making the day\u2019s session a clear decline in the market.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_Neuland_Laboratories\"><\/span><strong>What is the market capitalisation of Neuland Laboratories?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Neuland Laboratories has a market capitalisation of Rs 28,102.52 crore. The company is classified as Large Cap in the supplied data, which is useful context when reading the day\u2019s share price movement.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Neuland_Laboratories_compare_with_its_industry_peers\"><\/span><strong>How does Neuland Laboratories compare with its industry peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Neuland Laboratories\u2019 valuation is above the industry median, while its ROE and ROCE are also above the benchmark figures supplied. That combination places the stock in a distinct position within the Pharmaceuticals &amp; Drugs peer set.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_Neuland_Laboratories_valuation_ratios_show\"><\/span><strong>What do Neuland Laboratories\u2019 valuation ratios show?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;The company\u2019s P\/E is 56.46 and P\/B is 13.9. Those values are higher than the sector median figures supplied, so the stock is valued at a premium relative to the broader industry benchmark.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_EPS_and_book_value_say_about_Neuland_Laboratories\"><\/span><strong>What do EPS and book value say about Neuland Laboratories?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;EPS is Rs 387.98 and book value is Rs 1,575.41 per share. EPS reflects earnings attributable to each share, while book value shows the accounting net worth behind each share.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Neuland_Laboratories_part_of_the_Healthcare_sector\"><\/span><strong>Is Neuland Laboratories part of the Healthcare sector?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Yes. Neuland Laboratories belongs to the Healthcare sector and the Pharmaceuticals &amp; Drugs industry. This classification is important because the article compares the stock with same-industry companies and benchmark figures.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_investors_monitor_next_in_Neuland_Laboratories_Share_Price\"><\/span><strong>What should investors monitor next in Neuland Laboratories Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Investors can monitor whether the share price continues to trade around the day\u2019s low of Rs 21,423.7 or recovers toward the opening price of Rs 21,763.65. Valuation and sector comparison remain important context.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Neuland Laboratories Share Price falls to Rs 21,456.9. marking a 2.04% fall today. Market cap stands at Rs 28,102.52 crore.<\/p>\n","protected":false},"author":29,"featured_media":275219,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-275220","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["275219"],"rank_math_title":["Neuland Laboratories Share Price: price fall and valuation"],"rank_math_description":["Neuland Laboratories Share Price fell 2.04% to Rs 21,456.90 today. Read the price action, valuation, sector context and peer comparison."],"rank_math_focus_keyword":["Neuland Laboratories Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/neuland-laboratories-neulandlab-share-price-falls-2-04-today.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/275220","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=275220"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/275220\/revisions"}],"predecessor-version":[{"id":275221,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/275220\/revisions\/275221"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/275219"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=275220"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=275220"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=275220"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}